drugset / Trial / NCT01133353
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical trial is to study the therapeutic effect of tetrabenazine MR in children with Tourette's Syndrome, as measured by the improvement in total tic score of the Yale Global Tic Severity Scale (YGTSS).
Timeline
- Start
- 2011-03
- Primary completion
- 2011-11
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tetrabenazine | Unknown | 15 mg | — |
| Subject | Tetrabenazine | Unknown | 30 mg | — |
| Subject | Tetrabenazine | Unknown | 150 mg | — |